Painkillers without added safety features are expected to flood back into communities in the coming weeks unless the U.S. Food and Drug Administration takes preventive action, according to a national organization dedicated to reducing prescription drug abuse. Many popularly abused prescription painkillers, including OxyContin, have been reformulated in recent years to allegedly make them abuse-resistant. But many generic manufacturers are vying to bring their own versions of such drugs to market that don’t include tamper-proof properties. The FDA could allow these generic versions of the old formulations of the drugs to return to the market as early as January 2013, CLAAD says.
Earlier this month, CLAAD and nine other public health and safety organizations sent a letter to the FDA urging the agency to prevent the marketing of generic versions of the drugs that lack abuse-deterrent features.